IHRD-ARL undertakes formulation development of Pharmaceuticals ranging from immediate release formulations for oral administration to alternative dosage designs and controlled release formulations, aided by state-of-the-art technology and equipments. Formulation designs include Ethical Products.

Pharmaceutical Formulation Development

  • Solid oral
  • Topical dosage form
  • Parenterals

Activities involved

  • Literature Information & Primary Patent Status Evaluation
  • Preformulation study
  • Prototype Formulation Development
  • Packaging Development
  • Scale-up of selected Prototype Formulation
  • Process Optimization
  • Process Validation
  • Manufacture of Exhibit/Bio-batch
  • Bio-Equivalence Study
  • Product Development Report
  • Documentation in CTD Format
  • Technology Transfer
  • Stability Study